PHI with Neuroaxonal Dystrophy

How does this condition affect your private health insurance?

Dystrophie neuroaxonale, or Neuroaxonal Dystrophy (NAD), is a rare, progressive neurodegenerative disorder marked by the accumulation of spheroid-like structures in nerve cell axons. The infantile form (INAD), linked to PLA2G6 gene mutations, typically manifests in early childhood with psychomotor regression, hypotonia evolving to spasticity, and seizures. As the disease progresses, children experience severe neurological decline, including loss of motor skills, cognitive function, and vision. There is no cure, and management focuses on supportive care, leading to a severely diminished quality of life and premature death.

PKV Risk Assessment

Very High Risk of Rejection

Individual, specialized PHI providers may still insure you, but with a significant surcharge.

Impact on Your Insurance Policy

Duration of Illness (Initial)

Gradual onset over several months to a year, with symptoms progressively worsening.

Duration of Illness (Lifetime)

Chronic and relentlessly progressive, typically leading to death within 5-10 years for the infantile form.

Cost of Treatment (Initial)

High, including extensive diagnostic testing (genetic, imaging) and initial multidisciplinary supportive care.

Cost of Treatment (Lifetime)

Very high, encompassing continuous specialized medical care, physical, occupational, and speech therapies, palliative care, and adaptive equipment.

Mortality Rate

Extremely high, especially in the severe infantile form, with most patients succumbing in early childhood.

Risk of Secondary Damages

Very high, including severe motor impairment, cognitive decline, visual loss, feeding difficulties, respiratory compromise, and recurrent infections.

Probability of Full Recovery

Negligible (practically 0%), as it is a progressive and currently incurable neurodegenerative condition.

Underlying Disease Risk

Low for unrelated underlying diseases; however, patients frequently develop severe secondary complications directly attributable to their neurological impairment, such as aspiration pneumonia or intractable epilepsy.

The information provided is for general informational purposes only and is not a substitute for professional medical or insurance advice. Always consult with a qualified professional for any health concerns or before making any insurance decisions.